Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Procoagulant Platelet Potential Is Inversely Correlated with Bleeding and Joint Disease in Severe Hemophilia A

Shawn M. Jobe, MD PhD, Amy L. Dunn, MD, Traci Leong, PhD

Blood (2018) 132 (Supplement 1): 1185.

https://doi.org/10.1182/blood-2018-99-117989

Published: 2018

Journal Articles

Disease and Treatment Knowledge Deficits in Patients with Mild and Moderate Hemophilia May Impact Transition Readiness

Amy L. Dunn, MD, Linda Casto, MSW, LSIW, Pamela Widener, RN, BSN, Charmaine Biega, RN, Joseph R Stanek, MS

Blood (2017) 130 (Supplement 1): 5636.

https://doi.org/10.1182/blood.V130.Suppl_1.5636.5636

Published: 2017

Journal Articles

Increasing Ideal Coagulation Factor Dosing in the Pediatric Emergency Department: A Quality Improvement Study

Meghan Jackson, DO, Michael A Storey, PharmD, MS, Michael Dunn, MD, Amy L. Dunn, MD

Blood (2017) 130 (Supplement 1): 2093.

https://doi.org/10.1182/blood.V130.Suppl_1.2093.2093

Published: 2017

Journal Articles

Thrombin Generation in Patients with Severe Hemophilia A May Be Variable but Predictive of Response to Treatment

Ruchika Sharma, MD, Amy L. Dunn, MD, Shawn M. Jobe, MD PhD, Traci Leong, PhD, Shannon L. Meeks, MD

Blood (2017) 130 (Supplement 1): 3687.

https://doi.org/10.1182/blood.V130.Suppl_1.3687.3687

Published: 2017

Journal Articles

A Feasibility and Usability Study of a Nursing Orchestrated, Customized 3 Dimensional Virtual Reality Environment in Children with Hemophilia Undergoing Routine Intravenous Procedures

Amy L. Dunn, MD, Jeremy Patterson, Charmaine Biega, RN

Blood (2017) 130 (Supplement 1): 3691.

https://doi.org/10.1182/blood.V130.Suppl_1.3691.3691

Published: 2017

Journal Articles

Unfractionated Heparin Use in Children: Clinical Outcomes in a Pediatric Cohort Managed Using an Anti-Factor Xa Based Nomogram

Surbhi Saini, MD, Katherine L Harsh, BS, Joseph R Stanek, MS, Sarah O'Brien, MD MSc, Amy L. Dunn, MD, Riten Kumar, MD MSc

Blood (2017) 130 (Supplement 1): 701.

https://doi.org/10.1182/blood.V130.Suppl_1.701.701

Published: 2017

Journal Articles

Platelet-Dependent Thrombin Generation Is Correlated with Phenotypic Severity in Severe Hemophilia a

Amy L. Dunn, MD, Traci Leong, PhD, Shawn M. Jobe, MD PhD

Blood (2017) 130 (Supplement 1): 2355.

https://doi.org/10.1182/blood.V130.Suppl_1.2355.2355

Published: 2017

Journal Articles

Pegylated Full-Length Recombinant Factor VIII with Extended Half-Life in Previously Treated Pediatric Patients with Hemophilia Α: Efficacy of Prophylaxis and Treatment By Time (of Day/of Week) of Occurrence of Bleeding

Eric S. Mullins, MD, Christine M. Knoll, MD, Amy L. Dunn, MD, Werner Engl, PhD Cstat, Marlies Sharkhawy, MA, Brigitt E. Abbuehl, MD

Blood (2016) 128 (22): 1409.

https://doi.org/10.1182/blood.V128.22.1409.1409

Published: 2016

Journal Articles

Target Joint Bleeding in Pediatric Patients with Hemophilia Α Receiving Twice Weekly Prophylaxis with a Pegylated Full-Length Recombinant Factor VIII with Extended Half-Life

Amy L. Dunn, MD, Alexis A. Thompson, MD MPH, Werner Engl, PhD Cstat, Marlies Sharkhawy, MA, Brigitt E. Abbuehl, MD

Blood (2016) 128 (22): 3778.

https://doi.org/10.1182/blood.V128.22.3778.3778

Published: 2016

Journal Articles

Impact of Erythrocytapheresis on Endogenous Anticoagulants in Sickle Cell Disease

Ruchika Sharma, MD, Gary Woods, BS, MD, Susan E Creary, MD, Kan Hor, MD, Cody Young, MD, Christina Gallagher, RN, BSN, Emily McLain, RN, BSN, Trevorline Mongol, RN, BSN, Brooke Cohen, RN, BSN, Riten Kumar, MD MSc, Amy L. Dunn, MD

Blood (2015) 126 (23): 4590.

https://doi.org/10.1182/blood.V126.23.4590.4590

Published: 2015

Journal Articles

Long-Term Orthopedic Effects Of Delaying Prophylaxis In Severe Hemophilia A Until Age 6 Years: Results Of The Joint Outcome Study Continuation (JOSc)

Marilyn J. Manco-Johnson, MD, Michael L Manco-Johnson, MD, Taylor A Blades, BS, Sharon Funk, DPT, Heidi Lane, DPT, Kevin McRedmond, MD, Amy L. Dunn, MD, Michael Recht, MD, PhD, Amy D. Shapiro, MD, Leonard A. Valentino, MD, Deborah Brown

Blood (2013) 122 (21): 210.

https://doi.org/10.1182/blood.V122.21.210.210

Published: 2013

Journal Articles

Epitope Specific Discrepancies Between Antibody Mediated Inhibition Of Recombinant Factor VIII and Plasma Derived Factor VIII Containing Von Willebrand Factor Affecting All Domains Of Factor VIII

Tami Livnat, PhD, Amy L. Dunn, MD, Shirley Azar-Avivi, Wallace Hunter Baldwin, B.S., Gili Kenet, MD, Shannon L. Meeks, MD

Blood (2013) 122 (21): 1089.

https://doi.org/10.1182/blood.V122.21.1089.1089

Published: 2013

Journal Articles

Proteolytically Inactivatable Factor VIII is Less Immunogenic than Factor VIII in a Murine Hemophilia A Model.

Shannon Meeks, MD, Ernest T Parker, BS, Amy L. Dunn, MD, John F Healey, BS, Pete Lollar, MD

Blood (2009) 114 (22): 27.

https://doi.org/10.1182/blood.V114.22.27.27

Published: 2009

Journal Articles

Factor VIII and Factor IX Mutation Analysis in 600 U.S. Hemophilia Patients: Correlation of Mutation Type with History of Inhibitor

Connie H. Miller, PhD, Craig Hooper, PhD, Thomas C. Abshire, MD, Paula L. Bockenstedt, MD, Doreen B. Brettler, MD, Jorge Di Paola, MD, Gita Massey, MD, Anne T. Neff, MD, Amy D. Shapiro, MD, Michael Tarantino, MD, Brian M. Wicklund, MD, MPH, Marilyn J. Manco-Johnson, MD, Amy L. Dunn, MD, Christine Knoll, MD, Melissa Creary, MPH, Jane Benson, Dorothy Ellingsen, Jennifer Driggers, J. Michael Soucie, PhD

Blood (2008) 112 (11): 1017.

https://doi.org/10.1182/blood.V112.11.1017.1017

Published: 2008

Journal Articles

Blood Induced Cartilage Changes in a Hemophilia A Murine Model.

Amy L. Dunn, MD, Bahig M. Shehata, MD

Blood (2007) 110 (11): 1152.

https://doi.org/10.1182/blood.V110.11.1152.1152

Published: 2007

NARROW

Procoagulant Platelet Potential Is Inversely Correlated with Bleeding and Joint Disease in Severe Hemophilia A

Disease and Treatment Knowledge Deficits in Patients with Mild and Moderate Hemophilia May Impact Transition Readiness

Increasing Ideal Coagulation Factor Dosing in the Pediatric Emergency Department: A Quality Improvement Study

Thrombin Generation in Patients with Severe Hemophilia A May Be Variable but Predictive of Response to Treatment

A Feasibility and Usability Study of a Nursing Orchestrated, Customized 3 Dimensional Virtual Reality Environment in Children with Hemophilia Undergoing Routine Intravenous Procedures

Unfractionated Heparin Use in Children: Clinical Outcomes in a Pediatric Cohort Managed Using an Anti-Factor Xa Based Nomogram

Platelet-Dependent Thrombin Generation Is Correlated with Phenotypic Severity in Severe Hemophilia a

Pegylated Full-Length Recombinant Factor VIII with Extended Half-Life in Previously Treated Pediatric Patients with Hemophilia Α: Efficacy of Prophylaxis and Treatment By Time (of Day/of Week) of Occurrence of Bleeding

Target Joint Bleeding in Pediatric Patients with Hemophilia Α Receiving Twice Weekly Prophylaxis with a Pegylated Full-Length Recombinant Factor VIII with Extended Half-Life

Impact of Erythrocytapheresis on Endogenous Anticoagulants in Sickle Cell Disease

Long-Term Orthopedic Effects Of Delaying Prophylaxis In Severe Hemophilia A Until Age 6 Years: Results Of The Joint Outcome Study Continuation (JOSc)

Epitope Specific Discrepancies Between Antibody Mediated Inhibition Of Recombinant Factor VIII and Plasma Derived Factor VIII Containing Von Willebrand Factor Affecting All Domains Of Factor VIII

Proteolytically Inactivatable Factor VIII is Less Immunogenic than Factor VIII in a Murine Hemophilia A Model.

Factor VIII and Factor IX Mutation Analysis in 600 U.S. Hemophilia Patients: Correlation of Mutation Type with History of Inhibitor

Blood Induced Cartilage Changes in a Hemophilia A Murine Model.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only